Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Information regarding our population showing the number of participants in each group, as well as the various biomarkers and both the median and Q1 and Q3 for the continuous variables. Regarding physical activity, the responses were recoded as follows: 1 = never, 2 = less than once per week, 3 = 1 to 2 times per week, 4 = 3 to 5 times per week, and 5 = daily. HbA1c was only calculated for the patients with type 1 diabetes. The percentage was calculated using only valid cases within each column. Significant p-values are marked in bold. | Total | Patients | | p-Value | Controls | p-Value | | | Fracture | No Fracture | | Fracture | No Fracture |: 25(OH)D3 (nmol/L) | 59.56 (46.25, 71.83) | 58.92 (44.20, 70.00) | 60.21(47.36, 71.66) | NS | 61.88 (47.74, 73.54) | 58.87 (45.31, 71.90) | NS

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants with type 1 diabetes were identified via the national diabetes register (NDR), and the control participants were selected from the Swedish general population by using the Swedish national population register.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

ApoA1 and ApoB Are Associated with Fracture Risk in Patients with Type 1 Diabetes

Study design awaiting verification · Journal of Clinical Medicine · 2026

Original publication title

ApoA1 and ApoB Are Associated with Fracture Risk in Patients with Type 1 Diabetes

Emma Paulsson; Sergiu Bogdan Catrina; Cecilia Toppe; Edwin van Asseldonk; Hans J. Arnqvist; Simona I. Chisalita

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Individuals with type 1 diabetes (T1D) have an increased fracture risk, but no clear biomarkers have been linked to this risk. ApoA1 and ApoB were selected due to their association with metabolic disturbances in T1D. Copeptin was included given emerging evidence that ADH influences bone remodeling and glucose metabolism. The aim of this study was to identify biomarkers associated with fractures in patients with T1D.

Methods:

This prospective, population-based study included 473 individuals with T1D and 465 individuals without diabetes. Fasting blood samples were collected at baseline, and fracture outcomes were assessed after approximately 10 years. ApoA1, ApoB, CRP, GFR, copeptin, and HbA1c were analyzed. Cox regression was used to evaluate associations with fracture risk, and results were calculated per unit increase.

Results:

In total, 91 fractures occurred. A Kaplan: Meier analysis was performed to compare fracture risk between the control group and individuals with T1D. The results demonstrated a higher risk of fractures over time in patients with T1D compared to controls (p-value 0.037). When we divided the population by patient/control status, we found that, after adjustment for all investigated variables (HbA1c, GFR, CRP, copeptin, age, smoking, cortisone treatment, physical activity, lipid-lowering medication, and gender), both ApoA1 (HR 4.290, CI 1.871 to 9.837, p-value < 0.001) and ApoB (HR 7.625, CI 1.995 to 29.138, p-value 0.003) remained independently associated with fracture risk in the T1D group.

Conclusions:

Higher ApoA1 and ApoB levels are associated with increased fracture risk in individuals with T1D, independently of confounders. Additionally, individuals with T1D have a higher overall fracture risk compared to controls.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Individuals with type 1 diabetes (T1D) have an increased fracture risk, but no clear biomarkers have been linked to this risk. ApoA1 and ApoB were selected due to their association with metabolic disturbances in T1D. Copeptin was included given emerging evidence that ADH influences bone remodeling and glucose metabolism. The aim of this study was to identify biomarkers associated with fractures in patients with T1D.

Source: Background:

Abstract: Results

In total, 91 fractures occurred. A Kaplan: Meier analysis was performed to compare fracture risk between the control group and individuals with T1D. The results demonstrated a higher risk of fractures over time in patients with T1D compared to controls (p-value 0.037). When we divided the population by patient/control status, we found that, after adjustment for all investigated variables (HbA1c, GFR, CRP, copeptin, age, smoking, cortisone treatment, physical activity, lipid-lowering medication, and gender), both ApoA1 (HR 4.290, CI 1.871 to 9.837, p-value < 0.001) and ApoB (HR 7.625, CI 1.995 to 29.138, p-value 0.003) remained independently associated with fracture risk in the T1D group.

Source: Results:

Abstract: Conclusions

Higher ApoA1 and ApoB levels are associated with increased fracture risk in individuals with T1D, independently of confounders. Additionally, individuals with T1D have a higher overall fracture risk compared to controls.

Source: Conclusions:
Authors’ abstract

Background:

Individuals with type 1 diabetes (T1D) have an increased fracture risk, but no clear biomarkers have been linked to this risk. ApoA1 and ApoB were selected due to their association with metabolic disturbances in T1D. Copeptin was included given emerging evidence that ADH influences bone remodeling and glucose metabolism. The aim of this study was to identify biomarkers associated with fractures in patients with T1D.

Methods:

This prospective, population-based study included 473 individuals with T1D and 465 individuals without diabetes. Fasting blood samples were collected at baseline, and fracture outcomes were assessed after approximately 10 years. ApoA1, ApoB, CRP, GFR, copeptin, and HbA1c were analyzed. Cox regression was used to evaluate associations with fracture risk, and results were calculated per unit increase.

Results:

In total, 91 fractures occurred. A Kaplan: Meier analysis was performed to compare fracture risk between the control group and individuals with T1D. The results demonstrated a higher risk of fractures over time in patients with T1D compared to controls (p-value 0.037). When we divided the population by patient/control status, we found that, after adjustment for all investigated variables (HbA1c, GFR, CRP, copeptin, age, smoking, cortisone treatment, physical activity, lipid-lowering medication, and gender), both ApoA1 (HR 4.290, CI 1.871 to 9.837, p-value < 0.001) and ApoB (HR 7.625, CI 1.995 to 29.138, p-value 0.003) remained independently associated with fracture risk in the T1D group.

Conclusions:

Higher ApoA1 and ApoB levels are associated with increased fracture risk in individuals with T1D, independently of confounders. Additionally, individuals with T1D have a higher overall fracture risk compared to controls.

Publication and source details

Original title: ApoA1 and ApoB Are Associated with Fracture Risk in Patients with Type 1 Diabetes

Emma Paulsson; Sergiu Bogdan Catrina; Cecilia Toppe; Edwin van Asseldonk; Hans J. Arnqvist; Simona I. Chisalita

Journal of Clinical Medicine · 2026

* Correspondence: emmpa721@student.liu.se; Tel.: +46-704920076© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Forskningsrådet i Sydöstra Sverigehttps://ror.org/00brmfv24 FORSS-1034301This research received funding from FORSS, (forskningsrådet i sydöstra Sverige) number FORSS-1034301.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:25:36.664263+00:00

DOI: 10.3390/jcm15083019 · PMC13117660